This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Bioinformatics Remove Engineer Remove Gerontology Related Topics
Clinical Development Medicine Gene Regulation Clinical Trials Trials Development Research Clinical Trials More Related Topics >
article thumbnail

Insilico Medicine gets $255 million to boost AI-powered R&D, announces a collaboration

Scienmag

JUNE 22, 2021

Credit: Insilco June 22, 2021, New York / Hong Kong — Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine’s current therapeutic programs into (..)

Medicine 55
Medicine Clinical Trials Clinical Trials Clinical Development 55
article thumbnail

International team identifies a new regulatory pathway in bladder cancer

Scienmag

AUGUST 20, 2020

GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma Credit: Insilico Medicine August 20th, 2020, Hong Kong – Researchers from Johns Hopkins University in collaboration with Insilico Medicine announce the publication of a new research paper titled “GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma” (..)

Regulation 52
Regulation Medicine Research Bioinformatics 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024